Machine Learning Model Based on the Neutrophil-to-Eosinophil Ratio Predicts the Recurrence of Hepatocellular Carcinoma After Surgery

被引:6
作者
Shao, Guanming [1 ]
Ma, Yonghui [1 ]
Qu, Chao [1 ]
Gao, Ruiqian [1 ]
Zhu, Chengzhan [1 ]
Qu, Linlin [1 ]
Liu, Kui [1 ]
Li, Na [1 ]
Sun, Peng [1 ]
Cao, Jingyu [1 ]
机构
[1] Qingdao Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Hosp, Qingdao 266000, Shandong, Peoples R China
关键词
hepatocellular carcinoma; liver resection; recurrence; machine learning; neutrophil-to-eosinophil ratio; INTRAHEPATIC RECURRENCE; CANCER; OUTCOMES;
D O I
10.2147/JHC.S455612
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Circulating eosinophils are associated with tumor development. An eosinophil-related index, the neutrophil to eosinophil ratio (NER), can be used to predict the prognosis of patients with tumors. However, there is still a lack of efficient prognostic biomarkers for HCC. In this study, we aimed to investigate the predictive value of the NER and develop an optimal machine learning model for the recurrence of HCC patients. Patients and methods: A retrospective collection of 562 patients who underwent hepatectomy with a pathologic diagnosis of HCC was performed. The relationship between NER and progression -free survival (PFS) was investigated. We developed a new machine learning framework with 10 machine learning algorithms and their 101 combinations to select the best model for predicting recurrence after hepatectomy. The performance of the model was assessed by the area under the curve (AUC) of characteristics and calibration curves, and clinical utility was evaluated by decision curve analysis (DCA). Results: Kaplan-Meier curves showed that the PFS in the low NER group was significantly better than that in the high NER group. Multivariate Cox regression analysis showed that NER was an independent risk factor for recurrence after surgery. The random survival forests (RSF) model was selected as the best model that had good predictive efficacy and outperformed the TNM, BCLC, and CNLC staging systems. Conclusion: The NER has good predictive value for postoperative recurrence in patients with hepatocellular carcinoma. Machine learning model based on NER can be used for accurate predictions.
引用
收藏
页码:679 / 691
页数:13
相关论文
共 30 条
  • [1] Bray Freddie, 2018, CA Cancer J Clin, V68, P394, DOI [10.3322/caac.21609, 10.3322/caac.21492]
  • [2] Eosinophils orchestrate cancer rejection by normalizing tumor vessels and enhancing infiltration of CD8+ T cells
    Carretero, Rafael
    Sektioglu, Ibrahim M.
    Garbi, Natalio
    Salgado, Oscar C.
    Beckhove, Philipp
    Haemmerling, Guenter J.
    [J]. NATURE IMMUNOLOGY, 2015, 16 (06) : 609 - +
  • [3] Development of a Novel Inflammation-Based Index for Hepatocellular Carcinoma
    Chan, Stephen Lam
    Wong, Lin-Lee
    Chan, Kwan-Chee Allen
    Chow, Chit
    Tong, Joanna Hung-Man
    Yip, Terry Cheuk-Fung
    Wong, Grace Lai-Hung
    Chong, Charing Ching-Ning
    Liu, Po-Hong
    Chu, Cheuk-Man
    Wong, Vincent Wai-Sun
    To, Ka-Fai
    Reeves, Helen L.
    Chan, Anthony Wing-Hung
    [J]. LIVER CANCER, 2020, 9 (02) : 167 - 181
  • [4] Eosinophils and Cancer
    Davis, Benjamin P.
    Rothenberg, Marc E.
    [J]. CANCER IMMUNOLOGY RESEARCH, 2014, 2 (01) : 1 - 8
  • [5] Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms
    Elinav, Eran
    Nowarski, Roni
    Thaiss, Christoph A.
    Hu, Bo
    Jin, Chengcheng
    Flavell, Richard A.
    [J]. NATURE REVIEWS CANCER, 2013, 13 (11) : 759 - 771
  • [6] The Association of Clinical Outcomes with Posttreatment Changes in the Relative Eosinophil Counts and Neutrophil-to-Eosinophil Ratio in Patients with Advanced Urothelial Carcinoma Treated with Pembrolizumab
    Furubayashi, Nobuki
    Minato, Akinori
    Negishi, Takahito
    Sakamoto, Naotaka
    Song, Yoohyun
    Hori, Yoshifumi
    Tomoda, Toshihisa
    Tamura, Shingo
    Kuroiwa, Kentaro
    Seki, Narihito
    Fujimoto, Naohiro
    Nakamura, Motonobu
    [J]. CANCER MANAGEMENT AND RESEARCH, 2021, 13 : 8049 - 8056
  • [7] Risk factors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
    Imamura, H
    Matsuyama, Y
    Tanaka, E
    Ohkubo, T
    Hasegawa, K
    Miyagawa, S
    Sugawara, Y
    Minagawa, M
    Takayama, T
    Kawasaki, S
    Makuuchi, M
    [J]. JOURNAL OF HEPATOLOGY, 2003, 38 (02) : 200 - 207
  • [8] Kataoka S, 2004, DNA CELL BIOL, V23, P549, DOI 10.1089/1044549041939214
  • [9] Contributions of Eosinophils to Human Health and Disease
    Klion, Amy D.
    Ackerman, Steven J.
    Bochner, Bruce S.
    [J]. ANNUAL REVIEW OF PATHOLOGY: MECHANISMS OF DISEASE, VOL 15, 2020, 2020, 15 : 179 - 209
  • [10] Development and validation of a novel online calculator for estimating survival benefit of adjuvant transcatheter arterial chemoembolization in patients undergoing surgery for hepatocellular carcinoma
    Liang, Lei
    Li, Chao
    Wang, Ming-Da
    Wang, Hong
    Zhou, Ya-Hao
    Zeng, Yong-Yi
    Zhang, Wan-Guang
    Chen, Ting-Hao
    Wang, Nan-Ya
    Li, Jie
    Zhang, Yao-Ming
    Wang, Yu
    Gu, Wei-Min
    Xing, Hao
    Diao, Yong-Kang
    Lau, Wan Yee
    Zhang, Cheng-Wu
    Pawlik, Timothy M.
    Shen, Feng
    Huang, Dong-Sheng
    Yang, Tian
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)